 1.  Short title This Act may be cited as the  COVID–19 Vaccine Accountability Act . 
 2.  Liability of COVID–19 vaccine manufacturers  (a)  Covered countermeasure  Section 319F–3(i)(1) of the Public Health Service Act (42 U.S.C. 247d–6d(i)(1)) is amended by adding at the end the following:   Such term does not include vaccines for COVID–19 that are required (directly or as a condition of employment, schooling, or otherwise) under Federal, State, or local law to be administered to individuals eligible to receive such a vaccine.  .  (b)  Covered person  Section 319F–3(i)(2) of the Public Health Service Act (42 U.S.C. 247d–6d(i)(2)) is amended by adding at the end the following:  Such term does not include a manufacturer of a vaccine described in the matter following subparagraph (D) of paragraph (1).  .  (c)  Limitation of liability Section 319F–3 of the Public Health Service Act ( 42 U.S.C. 247d–6d ) is amended by adding at the end the following:  (j)  Limitation on liability  Pursuant to, and consistent with, the sovereign immunity reservation specified in subsection (f), the liability of the United States for a death or injury caused by the administration of a vaccine for COVID–19 occurring on or after January 1, 2020 shall not exceed $10,000.   . 
